AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20576092
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of methotrexate, sulfasalazine, and hydroxychloroquine with prednisolone (FIN‐RACo)
Trial: 12406334
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg pimecrolimus twice daily
Trial: 12406334
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg pimecrolimus twice daily
Trial: 8217026
Drug: lisinopril or
RxNorm normalized name: lisinopril Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lisinopril or isradipine
Trial: 3121861
Drug: Bupropion hydrochloride,
RxNorm normalized name: BuPROPion Hydrochloride, 75 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion hydrochloride, 225-450 mg/day
Trial: 29700636
Drug: High-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemotherapy with hematopoietic stem cell rescue, modified regimen including melphalan, carboplatin, and etoposide.
Trial: 29700636
Drug: High-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemotherapy (initial regimen before modification).
Trial: 29700636
Drug: Modified high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified high-dose chemotherapy regimen.
Trial: 24925270
Drug: MD supplemented
RxNorm normalized name: miconazole nitrate Topical Solution [Nail MD]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MD supplemented with 30 g/d of nuts (MD+Nuts)
Trial: 20724431
Drug: i.v. cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. cyclophosphamide (CYC) 0.5 g/m2 at 4-week intervals with low-dose prednisolone
Trial: 20724431
Drug: Low-dose prednisolone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prednisolone alone
Trial: 15728070
Drug: Oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral clonidine 100 microg
Trial: 12637258
Drug: Postprandial glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postprandial glucose profile (glucose peaked at 11.2 ± 0.5 mmol/l)
Trial: 8852389
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg sematilide HCl intravenous infusion over 30 minutes
Trial: 8852389
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg sematilide HCl tablet
Trial: 8852389
Drug: Intravenous and
RxNorm normalized name: immune globulin intravenous and subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous and oral administration of sematilide HCl
Trial: 1399032
Drug: Beta-carotene (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene (20 mg daily for 14 weeks)
Trial: 3893014
Drug: Diazepam 0.08
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 0.08 mg/kg
Trial: 30265691
Drug: Probiotic treatment
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic treatment (daily multi-strain capsule containing Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium lactis Bi-07, Bifidobacterium lactis B1-04)
Trial: 6724070
Drug: Acyclovir cream
RxNorm normalized name: Acyclovir Cream
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir cream
Trial: 15759526
Drug: Lower leg
RxNorm normalized name: CAPSAICIN 0.18 g in 100 g TOPICAL CLOTH [Nufabrx Lower Leg Sleeve]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower leg casting plus injections with botulinum toxin (group III)
Trial: 15759526
Drug: Lower leg
RxNorm normalized name: CAPSAICIN 0.18 g in 100 g TOPICAL CLOTH [Nufabrx Lower Leg Sleeve]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower leg casting plus injections with saline (group II)
Trial: 15759526
Drug: Current physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current physical treatment (group I)
Trial: 11831530
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (no intervention)
Trial: 9920138
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment at supraphysiological dosages (up to 8 IU/m2/d) for 4 years in the dose-response study.
Trial: 9920138
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment at a total dose of 6 IU/m2/d with low-dose ethinyl estradiol (50 ng/kg/d orally) in once-daily (OD) and twice-daily (BID) injection regimens for 2 years in the frequency-response study.
Trial: 9920138
Drug: Comparison with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison with healthy Dutch control subjects in the dose-response study.
Trial: 9920138
Drug: Increasing GH
RxNorm normalized name: FUSION PROTEIN OF HUMAN CHORIOGONADOTROPIN SUBUNIT .BETA. (CG- .BETA.)-(118-145)-PEPTIDE (1-28) WITH HUMAN SOMATOTROPIN (GROWTH HORMONE, GH) (29-219) AND TWO TANDEM COPIES OF HUMAN CHORIOGONADOTROPIN SUBUNIT .BETA. (CG-.BETA.)-(118-145)- PEPTIDE (220-247
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increasing GH dosage in the dose-response study.
Trial: 9920138
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment at supraphysiological dosages.
Trial: 7755523
Drug: Cognitive Analytical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Analytical Therapy
Trial: 7755523
Drug: Educational Behavioral
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Educational Behavioral Treatment
Trial: 355663
Drug: Cyclobenzaprine hydrochloride
RxNorm normalized name: Cyclobenzaprine Hydrochloride
DrugBank: Cyclobenzaprine (DB00924)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cyclobenzaprine hydrochloride (10 mg three times a day)
Trial: 31009099
Drug: Outcome studies
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Outcome studies of root canal treatment (n=35)
Trial: 25616430
Drug: Carboplatin AUC
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin AUC of 6 on day 1 and nab-paclitaxel 300 mg/m(2) on day 1 every 3 weeks
Trial: 25616430
Drug: Carboplatin AUC
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin AUC of 6 on day 1 and nab-paclitaxel 100 mg/m(2) on days 1, 8, and 15 every 21 days
Trial: 18697848
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health counseling and dental exam at baseline, followed by randomization and follow-up visits at 9, 12, 18, 24, 30, and 36 months postpartum.
Trial: 8852909
Drug: PRP-T conjugate
RxNorm normalized name: Haemophilus influenzae type b vaccine, PRP-T conjugate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP-T conjugate vaccine
Trial: 8852909
Drug: Diphtheria-tetanus-pertussis vaccine
RxNorm normalized name: DIPHTHERIA/TETANUS/PERTUSSIS VACCINE INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphtheria-tetanus-pertussis vaccine
Trial: 6359843
Drug: Propranolol (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (240 mg daily)
Trial: 6872409
Drug: Metoprolol (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (300 mg daily)
Trial: 18936218
Drug: 200 mg/d
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/d AA + (n‐3) LCPUFA (320 mg/d DHA, 80 mg/d eicosapentaenoic acid, 80 mg/d other (n‐3) fatty acids)
Trial: 18936218
Drug: 400 mg/d
RxNorm normalized name: ribociclib succinate 400 mg/day (200 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg/d AA + (n‐3) LCPUFA (320 mg/d DHA, 80 mg/d eicosapentaenoic acid, 80 mg/d other (n‐3) fatty acids)
Trial: 18936218
Drug: (n‐3) LCPUFA
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (n‐3) LCPUFA alone (320 mg/d DHA, 80 mg/d eicosapentaenoic acid, 80 mg/d other (n‐3) fatty acids)
Trial: 12756020
Drug: VAD combined
RxNorm normalized name: VAD-044
DrugBank: VAD-044 (DB17697)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAD combined with fludarabine (25 mg/m2/day i.v. for 5 days)
Trial: 10963641
Drug: Cyclophosphamide, methotrexate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide, methotrexate, and fluorouracil (CMF) adjuvant therapy
Trial: 10963641
Drug: No further
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No further treatment after surgery +/‐ radiotherapy (Control)
Trial: 8797150
Drug: L-arginine 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine 20 g/day
Trial: 8797150
Drug: L-arginine 10
RxNorm normalized name: RITE AID L-Arginine 1000mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine 10 microM
Trial: 26582396
Drug: H. pylori
RxNorm normalized name: H. PYLORI AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H. pylori treatment (n=87)
Trial: 25093169
Drug: Intensified and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified and modulated adjuvant treatment with a minimum dose of 64.8 Gy, higher doses of 70.2 Gy (85.4%), pelvic lymph nodes irradiation (57.7%), and/or hormonal therapy (69.1%)
Trial: 16186073
Drug: Oral hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral hormone replacement therapy (HRT)
Trial: 6624767
Drug: Daily home
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily home glucose monitoring
Trial: 6624767
Drug: Weekly venipuncture
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly venipuncture protocol
Trial: 29264836
Drug: Vorinostat (VOR)
RxNorm normalized name: Vorinostat
DrugBank: Vorinostat (DB02546)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vorinostat (VOR) 200 mg po alternating 7 days on then 7 days off throughout a 28-day cycle with Bevacizumab (BEV) 10 mg/kg iv every 2 weeks and daily Temozolomide (TMZ) 50 mg/m² po daily
Trial: 29264836
Drug: Vorinostat (VOR)
RxNorm normalized name: Vorinostat
DrugBank: Vorinostat (DB02546)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vorinostat (VOR) 400 mg po alternating 7 days on then 7 days off throughout a 28-day cycle with Bevacizumab (BEV) 10 mg/kg iv every 2 weeks and daily Temozolomide (TMZ) 50 mg/m² po daily
Trial: 26519119
Drug: Combined exercise
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined exercise prescription
Trial: 22484341
Drug: Group cognitive‐behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive‐behavioral therapy for insomnia and osteoarthritis pain (CBT‐PI)
Trial: 22484341
Drug: Group cognitive‐behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive‐behavioral therapy for osteoarthritis pain alone (CBT‐P)
Trial: 20849619
Drug: Care as
RxNorm normalized name: TopCare Aspirin 325mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Care as usual with the addition of occupational therapy
Trial: 17990475
Drug: Oral care
RxNorm normalized name: Oral Care Q4 Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral care via intermittent suction
Trial: 15847101
Drug: Artrofoon (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artrofoon (8 tablets daily, n = 30)
Trial: 15847101
Drug: Diclofenac (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (100 mg daily, n = 30)
Trial: 15847101
Drug: Artrofoon (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artrofoon (4 tablets daily)
Trial: 9785074
Drug: Org 9487
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 9487 1 mg kg‐1
Trial: 9785074
Drug: Org 9487
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 9487 2 mg kg‐1
Trial: 9785074
Drug: Org 9487
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 9487 3 mg kg‐1
Trial: 364364
Drug: Dipyridamole 225
RxNorm normalized name: Dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dipyridamole 225 mg/day and acetylsalicylic acid 1 gm/day
Trial: 28083842
Drug: VPZ 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VPZ 20 mg once daily for 3 weeks
Trial: 28083842
Drug: LPZ 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LPZ 30 mg once daily for 3 weeks
Trial: 19445938
Drug: Insulin resistance
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin resistance measured by HOMA2-IR
Trial: 16768836
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg supplemental Zn per day
Trial: 16768836
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg supplemental Zn per day
Trial: 16768836
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg supplemental Zn per day (placebo)
Trial: 14695850
Drug: Purine analogs
RxNorm normalized name: Purine analogs, antimetabolites antineoplastic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purine analogs alone or in combination with alkylating agents and monoclonal antibodies
Trial: 14695850
Drug: Alkylating agent-based
RxNorm normalized name: petroleum alkylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alkylating agent-based therapy
Trial: 11323555
Drug: Caffeine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (6 mg.kg‐1 of body mass)
Trial: 9460568
Drug: Nurse Specialist
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nurse Specialist Anticoagulant Service (NSAS)
Trial: 9460568
Drug: Consultant Anticoagulant
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Consultant Anticoagulant Service (CAS)
Trial: 7943793
Drug: Morphine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (0.1 mg/kg i.v.)
Trial: 7943793
Drug: Ketamine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.1 mg/kg i.v.)
Trial: 7943793
Drug: Adenosine +
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adenosine + Morphine
Trial: 3145269
Drug: Antimicrobial agents
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial agents (general)
Trial: 31980499
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg and 1000 mg)
Trial: 17145651
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of isoflavones, lignans and Cimicifuga racemosa (group A, n = 40)
Trial: 17145651
Drug: Calcium supplements
RxNorm normalized name: CALCIUM SUPPLEMENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplements (group B, n = 40)
Trial: 11760165
Drug: Induction treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction treatment (3 million units daily for the first 14 days, then 3 times per week)
Trial: 11760165
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (3 million units 3 times per week throughout)
Trial: 9268221
Drug: Tiqueside (1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiqueside (1, 2, and 3 g daily, b.i.d.)
Trial: 9268221
Drug: Tiqueside (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiqueside (2 or 4 g/day, once daily)
Trial: 8359182
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate (GTN) 0.4 mg
Trial: 8359182
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate (GTN) 0.8 mg
Trial: 3458681
Drug: Gel alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gel alone
Trial: 21988715
Drug: Acetil salicylic
RxNorm normalized name: salicylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetil salicylic acid (ASA) 100 mg daily until third month of pregnancy
Trial: 21988715
Drug: Low molecular-weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular-weight heparin (LMWH) - enoxaparine 40 mg daily until third month of pregnancy
Trial: 21988715
Drug: ASA 100
RxNorm normalized name: ASA 100 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA 100 mg plus LMWH 40 mg daily until third month of pregnancy
Trial: 21988715
Drug: ASA 100
RxNorm normalized name: ASA 100 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA 100 mg daily until third month of pregnancy
Trial: 10776982
Drug: GRADEX (granisetron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GRADEX (granisetron 3 mg i.v. + dexamethasone 20 mg i.v.)
Trial: 10776982
Drug: TRODEX (tropisetron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRODEX (tropisetron 5 mg i.v. + dexamethasone 20 mg i.v.)
Trial: 10776982
Drug: ONDEX (ondansetron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONDEX (ondansetron 8 mg i.v. + dexamethasone 20 mg i.v. followed by ondansetron 8 mg p.o. x 2)
Trial: 4016545
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin treatment (5000 units twice daily subcutaneously)
Trial: 4016545
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin treatment supplemented with graded compression stockings
Trial: 17687276
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg single-dose intravenous parecoxib
Trial: 12650956
Drug: Fluvoxamine 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine 300 mg/day
Trial: 10319772
Drug: Patient-controlled intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled intravenous analgesia with meperidine
Trial: 24894079
Drug: Negative pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative pressure wound therapy (NPWT) with innovative negative pressure device (NPD)
Trial: 16162997
Drug: Valacyclovir 500
RxNorm normalized name: valacyclovir 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir 500 mg BID for 7 days
Trial: 16162997
Drug: Valacyclovir 1000
RxNorm normalized name: valacyclovir 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir 1000 mg QD for 7 days
Trial: 10966246
Drug: Lorazepam (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (2 mg bolus plus 2 microg/kg/hr infusion for 4 hours)
Trial: 3937501
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg capsule of nifedipine
Trial: 3937501
Drug: 2 capsules
RxNorm normalized name: Xymogen Berberine With Insea2 Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 capsules (20 mg) of nifedipine
Trial: 3937501
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg tablet of nifedipine
Trial: 3937501
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg tablet of nifedipine
Trial: 3937501
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg tablet of nifedipine
Trial: 3937501
Drug: 2 X
RxNorm normalized name: anti-HER2 x HER2 ADC
DrugBank: Zanidatamab zovodotin (DB15472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 X 20 mg daily of the tablet form of nifedipine
Trial: 3937501
Drug: 2 X
RxNorm normalized name: anti-HER2 x HER2 ADC
DrugBank: Zanidatamab zovodotin (DB15472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 X 40 mg of the nifedipine tablets
Trial: 30006694
Drug: Centhaquin 0.015
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Centhaquin 0.015 mg/kg
Trial: 26092233
Drug: pegfilgrastim 6
RxNorm normalized name: PEGFILGRASTIM 6MG/0.6ML DELIVERY KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pegfilgrastim 6 mg
Trial: 15705376
Drug: N-acetyl-cysteine (NAC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetyl-cysteine (NAC) 1.2 g/d with clomiphene citrate (CC) 100 mg/d for 5 days
Trial: 15705376
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with clomiphene citrate (CC) 100 mg/d for 5 days
Trial: 12849761
Drug: Dopaminergic medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopaminergic medication (L-Dopa), specific dosage and duration not mentioned
Trial: 12849761
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of dopaminergic medication (off medication)
Trial: 10533471
Drug: Formestane (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formestane (250 mg intramuscularly every 2 weeks)
Trial: 8901143
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of chlorprothixene (100 mg)